-
Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants
A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant... Read more -
Most aspirin use in middle-aged adults may be unnecessary under new assessment
Rochester General Hospital, the University of Texas Southwestern Medical Center, and Aga Khan University report that applying newer cardiovascular risk... Read more -
Diabetes drugs show promise for treatment of alcohol use disorder
The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or alcoholism, is... Read more -
US regulator approves new generic abortion pill, conservatives outraged
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered... Read more -
Early medical abortion at home up to 12 weeks found to be safe, effective, comparable to hospital care
Early medical abortion at home up to 12 weeks of pregnancy is safe, effective, and comparable to hospital care, finds... Read more -
Topical cream calms chemotherapy side effects on the skin in clinical trial
Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a... Read more -
With extra study, nurses will be able to prescribe medications. Here's what to expect
Australia's health system is one of the highest quality and most equitable in the world.... Read more -
Diabetes drug may protect against kidney inflammation
A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just... Read more -
Alzheimer's disease medication shows promise for improving social impairment in some youth with autism
Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass... Read more -
FDA approves Inluriyo for advanced breast cancer
The U.S. Food and Drug Administration has approved Eli Lilly's Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the treatment... Read more -
Trump announces Pfizer deal he says will lower certain drug prices
The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant... Read more -
Combination of two drugs that fight cardiovascular risk could also help treat the most common liver disease
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult... Read more -
Sharp increase in gabapentin dispensing highlights need for awareness of adverse effects
A cross-sectional study examined dispensing of anticonvulsant gabapentin from retail pharmacies in the United States from 2010 to 2024. The... Read more -
Biologic drug reduces symptoms and hospitalization for severe pulmonary hypertension after diagnosis in clinical trial
Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood... Read more -
FDA approves Opzelura for atopic dermatitis in children
The U.S. Food and Drug Administration has approved Opzelura cream 1.5% (ruxolitinib) for children ages 2 to 11 years with... Read more
